ARCHIVES

Gemcitabine Improves DFS In Resected Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Bill Would Require Medicare to Reimburse Costs of Trials

March 7, 1997

Breast Cancer Task Force to Issue New RFPs In July, September

July 9, 1976

Hybridoma Cell Lines Available from NCI

September 3, 1982

NCI Told It Needs Overview Of Basic Research For Visibility And To Pursue Breakthroughs

July 14, 1978

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

Final NIH ethics rules retain consulting ban, but limit divesture requirement to senior employees.

September 9, 2005